戏说乾隆

Tech exchange drives China-Cambodia industrial cooperation at Phnom Penh machinery show_我的网站

放羊的星星

A |

A man tries a sewing machine during an international industrial expo in Phnom Penh, Cambodia, Aug. 15, 2026. A wide variety of advanced Chinese tech and manufacturing firms showcased cutting-edge machinery, automation, and innovative production solutions at a major international industrial exhibition here in Cambodia's capital. (Photo by Sovannara/Xinhua)A wide variety of advanced Chinese tech and manufacturing firms showcased cutting-edge machinery, automation, and innovative production solutions at a major international industrial exhibition here in Cambodia's capital.
The four-day expo, which runs from Thursday to Sunday, features more than 200 local and international exhibitors.
A significant portion of these participants comprises Chinese companies across four core sectors: machinery and automation, textiles and garments, plastics and rubber, and printing and packaging.
Organized by Yorkers Trade & Marketing Service Co., Ltd. in collaboration with the Ministry of Industry, Science, Technology & Innovation, the expo provided a platform to showcase emerging industrial technologies, foster business connections and support the modernization of Cambodia's manufacturing sector.
According to official ministry data, Cambodia had 3,357 operational factories as of July 2026. These facilities employ over 1.35 million workers, more than 70 percent of whom are women.
Total factory investment in the kingdom reached approximately 28 billion U.S. dollars, a 29 percent increase compared to the same period in 2025. Additionally, industrial production during the first half of 2026 was valued at over 9.8 billion dollars, including roughly 7.3 billion dollars in goods manufactured for export.
Cambodian Minister of Industry, Science, Technology and Innovation Hem Vanndy urged Cambodian enterprises to embrace advanced technologies to boost productivity, improve quality, and sharpen their competitive edge.
"Artificial intelligence, production-line automation, robotics, digital technologies and smart manufacturing are increasingly determining the competitiveness of nations," he said during the expo's opening ceremony on Thursday.
"Cambodia cannot remain outside this transformation," Vanndy said. "We must embrace new technologies to increase productivity, reduce costs, improve product quality and strengthen the competitiveness of our enterprises."
Chim Vinly, the expo's organizing staff member, said the exhibition plays a vital role in introducing innovative manufacturing technologies to Cambodia's garment sector, as attendees can explore a diverse range of advanced machinery designed to elevate production standards.
"Most exhibitors represent the textile and garment industries, with the majority being local and Chinese companies," he told Xinhua on Saturday.
"These advanced manufacturing tools have boosted productivity and modernized local production chains. In particular, they make work faster and more efficient," he added.
Vinly said the annual event plays a vital role in further expanding bilateral trade between China and Cambodia.
"Chinese investment is crucial to boosting Cambodia's economic growth and generating job opportunities for the local workforce," he said.
Bo Seyma, a mechanic at Kosin Sewing Machine Co., Ltd., which supplies Cambodian factories with equipment from the Shanghai-based Shang Gong Group, said the expo is vital for showcasing cutting-edge machinery to the local garment industry.
He said the Kosin company is promoting sewing, embroidery, button, and backstitching machines, along with other equipment, to factories in Cambodia.
"These industrial machines are in high demand, with numerous factories placing purchase orders with our company," he told Xinhua on Saturday.
Seyma said these advanced machines are high-quality and built to last.
"These machines accelerate production efficiency while effortlessly meeting customer demands," he said.
Thong Mengdavid, deputy director at the China-ASEAN Studies Center of the Cambodia University of Technology and Science, said that Cambodia, a country heavily dependent on textiles and garments, has seen its cooperation with China evolve from providing raw materials like fabrics and finished consumer goods toward technological cross-pollination.
This allows local Cambodian plant managers and entrepreneurs to evaluate high-grade machinery directly, he added.
"Integrating China's technology, machinery, and tools into Cambodian factories will address several challenges in the local economy, such as enhancing output per hour, reducing material waste caused by human error, and fostering skill development among the workforce," Mengdavid said.
People look at sewing machines during an international industrial expo in Phnom Penh, Cambodia, Aug. 15, 2026. A wide variety of advanced Chinese tech and manufacturing firms showcased cutting-edge machinery, automation, and innovative production solutions at a major international industrial exhibition here in Cambodia's capital. (Photo by Sovannara/Xinhua)

People look at sewing machines during an international industrial expo in Phnom Penh, Cambodia, Aug. 15, 2026. A wide variety of advanced Chinese tech and manufacturing firms showcased cutting-edge machinery, automation, and innovative production solutions at a major international industrial exhibition here in Cambodia's capital. (Photo by Sovannara/Xinhua)
。 AI设计的口服减重药有望2028年底上市

钱塘区生物医药产值已突破500亿元近日，杭州德睿智药科技有限公司宣布完成累计5200万美元B轮融资。2026年1月，杭州医药港，德睿智药一款名叫MDR-001的口服减重药，以令全球医药界瞩目的速度，启动Ⅲ期临床试验，成为国内首个进入临床Ⅲ期的AI小分子新药。

B | 这家仅40多人的公司，把一款一类创新药从立项到推进至Ⅲ期临床的时间，压缩到了4.5年。

C | 而传统同行完成同样的路程，通常需要8到12年。

D | 不用“大海捞针”了2021年初，85后海归博士牛张明，带着计算机和生物制药2个硕士学位、5种AI算法语言，在钱塘区成立了德睿智药。

E | 当时，他就想好了：“要走一条和传统制药完全不同的路。”传统新药研发有多难？业内有个“双十定律”，即成功研发一款创新药，平均需要10年的时间和10亿美元的投入。面对超过10的60次方级别、近乎无限的成药化学空间，科学家们只能靠经验和反复试错，如同在茫茫大海里捞针。

F | 牛张明说：“过去的药物发现，靠大量实验、反复试错，不仅耗时间，成功率也低。现在用上AI，好比给每位科学家配了一个‘超级大脑’做助手。”2026年，德睿智药基于MDR-001的研发流程，搭建起了由多智能体驱动的全链条AI制药引擎MAP。

G | 这个平台覆盖靶点发现、分子设计、多目标优化、实验验证及临床试验全链条。“药物分子就像精密的拼图，每个片段都决定着药效和安全性。

H | 以往，这全靠科研人员的经验和反复试错。”牛张明解释，“MAP能通过学习海量已知药物的成功与失败案例，自动预测分子片段的性质，大幅减少试错成本、缩短研发周期。”他打了一个比方：“你可以把它想象成一位高效且永不疲倦的‘分子组装专家’，在虚拟世界里高速筛选，帮研发人员提前排除大量‘错误选项’。”药物研发，就这样从“大海捞针”变成了“高清导航”。口服减重新药将于2028年底上市MDR-001是一款GLP-1（胰高血糖素样肽-1）受体激动剂，与市面上常见的减肥注射剂最大的不同在于，它可以口服。“我们立项时，口服GLP-1还没有出现。口服小分子药物的依从性更高，患者不需要消毒针头注射、不需要低温冷藏保存，使用更方便；在某些适应证上疗效甚至优于注射剂型。”牛张明说。在MDR-001项目中，团队仅耗时8个月、实际仅合成80个小分子，就获得了高质量的临床前候选药物。从立项到推进至Ⅲ期临床研究，整体仅耗时4.5年，单产品累计研发投入控制在约2300万美元。对比传统同类药物的研发周期和投入，这组数字可以称得上是“奇迹”了。